| Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a … D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 32 (10), 1245-1255, 2021 | 97 | 2021 |
| Examination of lower secondary mathematics teachers’ content knowledge and its connection to students’ performance M Tchoshanov, MD Cruz, K Huereca, K Shakirova, L Shakirova, ... International Journal of Science and Mathematics Education 15 (4), 683-702, 2017 | 96 | 2017 |
| The germline mutational landscape of BRCA1 and BRCA2 in Brazil EI Palmero, DM Carraro, B Alemar, MAM Moreira, A Ribeiro-dos-Santos, ... Scientific reports 8 (1), 9188, 2018 | 89 | 2018 |
| Desmoplastic small round cell tumor: a review of main molecular abnormalities and emerging therapy CA Mello, FAB Campos, TG Santos, MLG Silva, GT Torrezan, FDA Costa, ... Cancers 13 (3), 498, 2021 | 71 | 2021 |
| Inherited lung cancer: a review VTL de Alencar, MN Formiga, VCC de Lima Ecancermedicalscience 14, 1008, 2020 | 71 | 2020 |
| XAF1 as a modifier of p53 function and cancer susceptibility EM Pinto, BC Figueiredo, W Chen, HCR Galvao, MN Formiga, ... Science advances 6 (26), eaba3231, 2020 | 64 | 2020 |
| BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation RC Brianese, KDM Nakamura, FGSR Almeida, RF Ramalho, BDF Barros, ... Breast cancer research and treatment 167 (3), 803-814, 2018 | 62 | 2018 |
| From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America CA Vaccaro, F López‐Kostner, DV Adriana, EI Palmero, BM Rossi, ... International journal of cancer 145 (2), 318-326, 2019 | 40 | 2019 |
| Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial MLG Silva, CAL de Mello, SA Junior, FDA Costa, PR Stevanato Filho, ... Radiotherapy and Oncology 159, 161-167, 2021 | 31 | 2021 |
| Registros de representación semiótica del concepto de función exponencial M Castro, M González, S Flores, O Ramírez, M Cruz, M Fuentes Parte I. Entreciencias: diálogos en la Sociedad del Conocimiento 5 (13), 1-12, 2017 | 31 | 2017 |
| Frequency of thyroid carcinoma in Brazilian TP53 p. R337H carriers with Li Fraumeni syndrome MN da Cruz Formiga, KC De Andrade, LP Kowalski, MI Achatz Jama Oncology 3 (10), 1400-1402, 2017 | 31 | 2017 |
| Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil DP Cotrim, ARG Ribeiro, D Paixão, DC de Queiroz Soares, R Jbili, ... BMC cancer 19 (1), 4, 2019 | 29 | 2019 |
| High prevalence of EGFR mutations in lung adenocarcinomas from Brazilian patients harboring the TP53 p. R337H variant MVR Barbosa, VCC de Lima, MN Formiga, CAA de Paula, GT Torrezan, ... Clinical Lung Cancer 21 (2), e37-e44, 2020 | 26 | 2020 |
| PIVOT-09: A phase III randomized open-label study of bempegaldesleukin (NKTR-214) plus nivolumab versus sunitinib or cabozantinib (investigator's choice) in patients with … NM Tannir, N Agarwal, SK Pal, DC Cho, M Formiga, J Guo, DJ George, ... Journal of Clinical Oncology 38 (6_suppl), TPS763-TPS763, 2020 | 25 | 2020 |
| Assessment of treatment patterns for metastatic renal cell carcinoma in Brazil PG Bergerot, CD Bergerot, N Dizman, S Zequi, A Fay, Y Dara, MC Maia, ... Journal of global oncology 4, 1-8, 2017 | 25 | 2017 |
| Bempegaldesleukin plus nivolumab versus sunitinib or cabozantinib in previously untreated advanced clear cell renal cell carcinoma: a phase III randomized study (PIVOT-09) NM Tannir, MN Formiga, K Penkov, N Kislov, A Vasiliev, N Gunnar Skare, ... Journal of Clinical Oncology 42 (23), 2800-2811, 2024 | 23 | 2024 |
| Aortic dissection during antiangiogenic therapy with sunitinib. A case report MNC Formiga, MF Fanelli Sao Paulo Medical Journal 133 (3), 275-277, 2014 | 23 | 2014 |
| The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors JE Nuñez, M Donadio, D Rocha Filho, JF Rego, M Barros, MN Formiga, ... Journal of Gastrointestinal Oncology 10 (4), 645, 2019 | 22 | 2019 |
| Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with MSH2 Germline Pathogenic Variants N de Angelis de Carvalho, BN Niitsuma, VN Kozak, FD Costa, ... Cancers 12 (7), 1848, 2020 | 20 | 2020 |
| Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil MF Fanelli, TF de Paiva Jr, MJB Silva, CFL Benevides, APG Guimarães, ... Journal of surgical oncology 100 (6), 452-455, 2009 | 19 | 2009 |
